Marcum Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$526K Sell
4,696
-609
-11% -$62.8K 0.05% 187
2024
Q4
$490K Sell
5,305
-448
-8% -$40.3K 0.04% 202
2024
Q3
$482K Buy
5,753
+1,208
+27% +$92.2K 0.04% 205
2024
Q2
$312K Sell
4,545
-165
-4% -$11K 0.03% 264
2024
Q1
$345K Sell
4,710
-300
-6% -$23.1K 0.04% 244
2023
Q4
$406K Buy
5,010
+457
+10% +$35.6K 0.04% 208
2023
Q3
$341K Buy
4,553
+848
+23% +$65.2K 0.04% 220
2023
Q2
$286K Sell
3,705
-517
-12% -$41.2K 0.03% 257
2023
Q1
$350K Sell
4,222
-1,361
-24% -$113K 0.04% 224
2022
Q4
$479K Sell
5,583
-218
-4% -$17.3K 0.06% 172
2022
Q3
$358K Buy
5,801
+276
+5% +$17.4K 0.05% 206
2022
Q2
$342K Buy
5,525
+669
+14% +$41.4K 0.05% 216
2022
Q1
$289K Buy
4,856
+470
+11% +$30K 0.04% 249
2021
Q4
$318K Sell
4,386
-193
-4% -$13.3K 0.04% 238
2021
Q3
$320K Buy
4,579
+645
+16% +$45.3K 0.05% 228
2021
Q2
$271K Buy
3,934
+201
+5% +$13.4K 0.04% 233
2021
Q1
$241K Buy
+3,733
New +$241K 0.04% 253

Other funds holding GILD

Marcum Wealth's GILD Position: Q1 2025 in Review

Marcum Wealth reduced its Gilead Sciences (GILD) stake by 11% in Q1 2025, selling an estimated $62.8K and leaving 4,696 shares worth $526K. The position accounts for 0.05% of the portfolio, ranked #187.

Marcum Wealth first reported a position in GILD in Q1 2021 and has held it in 17 quarters since. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.

  • Marcum Wealth held 4,696 shares of Gilead Sciences worth $526K as of Q1 2025.
  • Marcum Wealth sold 609 Gilead Sciences shares in Q1 2025, an estimated $62.8K.
  • Gilead Sciences made up 0.05% of Marcum Wealth's portfolio in Q1 2025, its #187 holding.
  • Marcum Wealth first reported a position in Gilead Sciences in Q1 2021 and has held it in 17 quarters since.
  • 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.

Based on Marcum Wealth's 13F filing for Q1 2025, filed 2 Apr 2025.